125 related articles for article (PubMed ID: 8378939)
1. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes.
Wood SC; Jeong HG; Morris DL; Holsapple MP
Toxicology; 1993 Jul; 81(2):131-43. PubMed ID: 8378939
[TBL] [Abstract][Full Text] [Related]
2. Distribution and behavior of the Ah receptor in murine T lymphocytes.
Lawrence BP; Leid M; Kerkvliet NI
Toxicol Appl Pharmacol; 1996 Jun; 138(2):275-84. PubMed ID: 8658529
[TBL] [Abstract][Full Text] [Related]
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor.
Schrenk D; Schäfer S; Bock KW
Carcinogenesis; 1994 Jan; 15(1):27-31. PubMed ID: 8293544
[TBL] [Abstract][Full Text] [Related]
4. Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro.
Lang DS; Becker S; Clark GC; Devlin RB; Koren HS
Arch Toxicol; 1994; 68(5):296-302. PubMed ID: 8085940
[TBL] [Abstract][Full Text] [Related]
5. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
Blank JA; Tucker AN; Sweatlock J; Gasiewicz TA; Luster MI
Mol Pharmacol; 1987 Jul; 32(1):169-72. PubMed ID: 3037301
[TBL] [Abstract][Full Text] [Related]
6. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
Snyder NK; Kramer CM; Dooley RK; Holsapple MP
Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-TCDD induces cytochrome P450 enzyme activity but not proliferation or phenotypical changes in human peripheral blood lymphocytes.
Lang DS; Becker S; Devlin RB; Koren HS
Toxicol Lett; 1996 Nov; 88(1-3):317-25. PubMed ID: 8920755
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
9. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
Shen ES; Guengerich FP; Olson JR
Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 1A1 induction in rat lymphoid tissues following in vivo and in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin requires protein kinase C.
Stephen FD; Drahushuk AT; Olson JR
Toxicology; 1997 Dec; 124(1):39-51. PubMed ID: 9392454
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Karras JG; Holsapple MP
Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
[TBL] [Abstract][Full Text] [Related]
12. An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus.
Cook JC; Dold KM; Greenlee WF
Toxicol Appl Pharmacol; 1987 Jun; 89(2):256-68. PubMed ID: 3037728
[TBL] [Abstract][Full Text] [Related]
13. Expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P4501A1 in human splenic lymphocyte cultures.
Jeong HG; Yang KH
Cancer Lett; 1996 Jan; 98(2):193-8. PubMed ID: 8556708
[TBL] [Abstract][Full Text] [Related]
14. Integration of the human lymphocyte into immunotoxicological investigations.
Wood SC; Karras JG; Holsapple MP
Fundam Appl Toxicol; 1992 Apr; 18(3):450-9. PubMed ID: 1597269
[TBL] [Abstract][Full Text] [Related]
15. Serum modulation of the effects of TCDD on the in vitro antibody response and on enzyme induction in primary hepatocytes.
Morris DL; Jeong HG; Stevens WD; Chun YJ; Karras JG; Holsapple MP
Immunopharmacology; 1994; 27(2):93-105. PubMed ID: 8014031
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S
Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892
[TBL] [Abstract][Full Text] [Related]
17. Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Doi H; Baba T; Tohyama C; Nohara K
Chemosphere; 2003 Jul; 52(4):655-62. PubMed ID: 12738279
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells.
Morris DL; Karras JG; Holsapple MP
Immunopharmacology; 1993; 26(2):105-12. PubMed ID: 8282534
[TBL] [Abstract][Full Text] [Related]
19. Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDD.
Wood SC; Holsapple MP
Toxicol Appl Pharmacol; 1993 Oct; 122(2):308-13. PubMed ID: 8212013
[TBL] [Abstract][Full Text] [Related]
20. Cell-specific differences in the susceptibility of potential cellular targets of human origin derived from blood and lung following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Lang DS; Becker S; Devlin RB; Koren HS
Cell Biol Toxicol; 1998 Feb; 14(1):23-38. PubMed ID: 9538942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
